The study authors noted that the medications show promise in improving alcohol use disorder (AUD), opioid use disorder (OUD), and tobacco use disorder by modulating neurobiological pathways underlying addictive behaviors, potentially reducing substance craving.1,2 Image credit: O.Farion | stock.adobe.com Early research in both animals and humans suggests that these treatments may help reduce alcohol and other substance use, Lorenzo Leggio, MD, PhD, of the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), both part of the National Institutes of Health (NIH) in Bethesda, Maryland, and lead study author, said in a news release
Mechanism of Action The active ingredient in Ozempic, semaglutide, is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist
Lalor, P
Keep the lyophilized vial in a freezer at -20C away from direct light
Other cancers Zinc homeostasis disruption has been observed in patients with various types of cancers
So I turned to science the only thing that made sense when my body and mind didnt
